ClinVar Miner

Submissions for variant NM_001378454.1(ALMS1):c.6537C>T (p.Thr2179=) (rs371511963)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000730690 SCV000532474 likely benign not provided 2019-04-18 criteria provided, single submitter clinical testing
Eurofins NTD, LLC RCV000730690 SCV000858448 uncertain significance not provided 2017-12-20 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000431183 SCV000864115 uncertain significance not specified 2017-03-06 criteria provided, single submitter clinical testing Variant summary: The ALMS1 c.6534C>T (alternative name c.6540C>T) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. Mutation Taster predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect binding of ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 15/120306 control chromosomes at a frequency of 0.0001247, which does not exceed the estimated maximal expected allele frequency of a pathogenic ALMS1 variant (0.0022361). The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as VUS-possibly benign.
Invitae RCV001084643 SCV001003203 likely benign Alstrom syndrome 2020-11-25 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000431183 SCV001365661 likely benign not specified 2017-08-23 criteria provided, single submitter clinical testing p.Thr2178Thr in exon 8 of ALMS1: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.02% (13/66518) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs371511963).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.